HOME >> BIOLOGY >> NEWS
New treatment for fibromyalgia

Fibromyalgia is a chronic, incapacitating musculoskeletal disorder. Nearly six times more common in women than in men, fibromyalgia is marked by widespread body pain and muscle tenderness, often accompanied by headaches, sleep disturbances, and fatigue. While its cause remains a mystery, fibromyalgia has been linked to abnormalities in the brain's neurotransmitters, serotonin and norepinephrine--chemicals key to mood and widely recognized for their role in depression. Not all patients with fibromyalgia, however, have depression or respond to antidepressants. Treatment studies of the other types of antidepressant drugs, including selective serotonin uptake inhibitors and tricyclic agents, have had mixed results.

A new and different antidepressant, duloxetine, works by inhibiting the reuptake of both serotonin and norepinephrine. In a recent clinical trial conducted for the treatment of fibromyalgia--one of the largest ever--duloxetine was shown to reduce pain and improve a range of disease symptoms, significantly and safely. The results, published in the September 2004 issue of Arthritis & Rheumatism, offer the promise of relief for women with fibromyalgia.

"Our results suggest that duloxetine improves pain and tenderness, the hallmark characteristics of fibromyalgia," states Lesley M. Arnold, M.D., who coordinated the research at 18 centers, including the University of Cincinnati College of Medicine, Indiana University Medical School, and Harvard Medical School. "The effect of duloxetine on the reduction of pain," Dr. Arnold further notes, "appears to be independent of its effect on mood."

To test duloxetine's effectiveness on the range of symptoms, researchers recruited 207 patients, all meeting the American College of Rheumatology criteria for fibromyalgia. Like the majority of those with this disease, the majority of the participants--89 percent--were women. 87 percent of the subjects were Caucasian and the mean age was 49. J
'"/>

Contact: Amy Molnar
amolnar@wiley.com
201-748-8844
John Wiley & Sons, Inc.
9-Sep-2004


Page: 1 2

Related biology news :

1. Leader in cancer treatment and prevention research honored
2. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
3. New study indicates arsenic could be suitable as first-line treatment in type of leukaemia
4. The impact of genetic variations on the treatment of early rheumatoid arthritis
5. OneWorld Health compiles comprehensive state of infectious diarrhea treatments, potential solutions
6. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
7. Colleagues to recognize research leadership in cancer detection, prevention and treatment
8. New view of leukemia cells identifies best treatment options, Stanford researchers say
9. Genetic model for devastating form of paraplegia suggests new treatments
10. Protective mechanism exploited by tumors may provide new cancer treatment
11. Gene profiles could improve acute leukemia diagnosis and lead to better treatments

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 13, 2019 , ... Dr. Julie Reck of Veterinary Medical Center of Fort Mill ... Her first stem cell patient, her own geriatric Australian Shepherd, Simon, was treated in June ... wanted to play but his body was weak, and he struggled to play fetch and ...
(Date:8/6/2019)... DURHAM, N.C. (PRWEB) , ... August 06, 2019 ... ... Medicine (SCTM) identifies a computational modeling system that could have far-reaching implications for ... called partial least squares regression (PLSR), is able to predict which stem cell ...
(Date:8/6/2019)... ... 2019 , ... Keck Graduate Institute (KGI) President Sheldon Schuster has announced Martin ... , “Dean Zdanowicz is highly regarded as an innovative leader who prioritizes student success ... great choice to build on the success of the KGI School of Pharmacy and ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 06, 2019 , ... Shoreline Biome, a ... strain level, has announced partnerships with six international distributors. , The distributors ... organizations in Australia, Benelux, Indonesia, Korea, Malaysia, Myanmar, New Zealand, Singapore, the United ...
(Date:7/26/2019)... ... July 25, 2019 , ... LeadingBiotech , an exclusive ... announces its Boston BD conference to be held on September 10, ... Boston , the event provides an opportunity for attendees to leverage insight from ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for ... will have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing center ...
(Date:7/2/2019)... POWAY, Calif. (PRWEB) , ... July 02, 2019 , ... ... new documentary entitled Animal Pharm: Where Beasts Meet Biotech. The film focuses on ... and wild animals. Animal Pharm was recently included in the Brentwood ...
Breaking Biology Technology:
Cached News: